Gardasil 9 2 dose regimen

BIOLOGICAL2 trials

Sponsors

Boston Medical Center, Karolinska Institutet

Conditions

HPV InfectionIncident HPV16, 18, 31, 33, 45, 52 or 58 Infection

Phase 4

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Active, not recruitingNCT04206813

Boston Medical CenterHPV Infection

Start: 2020-12-01End: 2026-10-01Updated: 2026-04-29

Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening

Active, not recruitingNCT07314307

Karolinska InstitutetIncident HPV16, 18, 31, 33, 45, 52 or 58 Infection

Start: 2021-05-03End: 2028-12-31Target: 150000Updated: 2026-01-02